One mechanism through which CML affects cellular function is binding to the receptor for AGEs and activating intracellular signaling pathways such as NF-κB [50, 51], which could contribute to the pathogenesis of NAFLD. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.